These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 9231053)

  • 1. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.
    Neyzi O; Yordam N; Ocal G; Bundak R; Darendeliler F; Açikgöz E; Berberoğlu M; Günöz H; Saka N; Calikoğlu AS
    Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency.
    Chen RG; Shen YN; Yei J; Wang CF; Xie DH; Wang XH; Zhou JD; Chen CY; Wu YL; Gunnarsson R
    Acta Paediatr Suppl; 1993 Mar; 388():32-5; discussion 36. PubMed ID: 8329830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.
    Kirk JM; Trainer PJ; Majrowski WH; Murphy J; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):487-93. PubMed ID: 7955460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) profiles in response to continuous subcutaneous infusion of GH-releasing hormone(1-29)-NH2 in children with GH deficiency.
    Tauber MT; Pienkowski C; Pigeon P; Cataldi M; Rochiccioli P
    Acta Paediatr Suppl; 1993 Mar; 388():28-30; discussion 31. PubMed ID: 8329829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.
    Thorner M; Rochiccioli P; Colle M; Lanes R; Grunt J; Galazka A; Landy H; Eengrand P; Shah S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1189-96. PubMed ID: 8772599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
    Sulmont V; Brauner R; Fontoura M; Rappaport R
    Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growth.
    Hümmelink R; Sippell WG; Benoit KG; Danielson K; Faijerson Y
    Acta Paediatr Suppl; 1993 Mar; 388():23-6; discussion 27. PubMed ID: 8329828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation and neuroregulatory control of growth hormone secretion.
    Ogilvy-Stuart AL; Wallace WH; Shalet SM
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy.
    Duck SC; Schwarz HP; Costin G; Rapaport R; Arslanian S; Hayek A; Connors M; Jaramillo J
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1115-20. PubMed ID: 1400880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Ross RJ; Rodda C; Tsagarakis S; Davies PS; Grossman A; Rees LH; Preece MA; Savage MO; Besser GM
    Lancet; 1987 Jan; 1(8523):5-8. PubMed ID: 2879138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone state after completion of treatment with growth hormone.
    Clayton PE; Price DA; Shalet SM
    Arch Dis Child; 1987 Mar; 62(3):222-6. PubMed ID: 3566314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth response to growth hormone therapy following craniospinal irradiation.
    Clayton PE; Shalet SM; Price DA
    Eur J Pediatr; 1988 Aug; 147(6):597-601. PubMed ID: 3181200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth response to growth hormone therapy following cranial irradiation.
    Clayton PE; Shalet SM; Price DA
    Eur J Pediatr; 1988 Aug; 147(6):593-6. PubMed ID: 3181199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC; Malozowski S; Caruso-Nicoletti M; Ross JL; Pescovitz OH; Rose S; Loriaux DL; Cassorla F; Merriam GR
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.